Oncomine assessment exhibited that CRIM1 was remarkably downregulated in breast cancer compared with normal tissue, including in infiltrative ductal carcinoma, infiltrative lobular carcinoma, and medullary carcinoma (Figure 1; Table 1). This evidence concerns the gene CRIM1 and invasive ductal breast carcinoma.